SLC6A11 and Alzheimer disease: This synaptic hyperexcitability was evident in both wild-type and AD tissue with bath application of the GAT3/4 blocker, which is not the desired outcome in a system that is altered and in a ‘hyperactive’ state as indicated by the differences in the resting membrane potentials observed between mice cohorts in control conditions.